LAUREATE PHARMA AND ENOBIA PHARMA ANNOUNCE DEVELOPMENT AND MANUFACTURING AGREEMENT

Laureate Pharma, Inc. and Enobia Pharma, Inc. announced today that they have entered into a biopharmaceutical development and manufacturing agreement for process development and manufacture of cGMP batches of Enobia's recombinant enzyme sPHEX Metallo Peptidase. The project is well underway and Laureate Pharma expects to supply Enobia with material for their Phase I clinical trials in 3Q 2006. Terms of the agreement were not disclosed.

PR Newswire (http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-21-2005/0004112335&EDATE=)